Latest News and Press Releases
Want to stay updated on the latest news?
-
BEDFORD, MA--(Marketwire - Feb 6, 2013) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the...
-
PRINCETON, NJ--(Marketwire - Feb 6, 2013) - Agile Therapeutics announced today that Dr. Marie Foegh, the company's Chief Medical Officer and Vice President of Clinical Research and Development, has...
-
PRINCETON, MA--(Marketwire - Jan 31, 2013) - Local kids and teens will soon learn how to shred down the mountain and balance blood sugars in the second annual Riding on Insulin East Coast...
-
PARIS--(Marketwire - Jan 30, 2013) - Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, reported its...
-
Insulet Appoints Tracey H. Wielinski as VP, Global Regulatory/Clinical Affairs and Quality Assurance
BEDFORD, MA--(Marketwire - Jan 23, 2013) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...
-
YOQNEAM, ISRAEL--(Marketwire - Jan 23, 2013) - Given Imaging (NASDAQ: GIVN) today announced that the company will host a conference call on Wednesday, February 13, 2013 at 9:00am ET, 4:00pm Israel...
-
BOSTON, MA--(Marketwire - Jan 22, 2013) - Massachusetts General Hospital is evaluating a new treatment for heart failure in a clinical study to treat this condition through nerve stimulation in the...
-
YOQNEAM, ISRAEL--(Marketwire - Jan 17, 2013) - Given Imaging Ltd (NASDAQ: GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced that effective January...
-
PARIS--(Marketwire - Jan 15, 2013) - Mauna Kea Technologies (EURONEXT PARIS: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced...
-
YOQNEAM, ISRAEL--(Marketwire - Jan 15, 2013) - Given Imaging (NASDAQ: GIVN) today announced that it is ending its previously announced exploration of a possible sale or merger transaction as part...